BioVie Inc. (BIVI) Key Metrics
BIVI valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $10.4M
- Enterprise value
- $5.2M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- —
- Price / book
- 1.4
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 0.73
BIVI key metrics, FY2017–FY2026
Fiscal year ended June 30, 2026 · U.S. dollarsBIVI returns How much profit the business earns on the capital it uses.
BIVI financial health Debt, liquidity and how easily interest is covered.
BIVI valuation history
BIVI returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BIVI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BIVI cash returned to shareholders
BIVI price vs earnings per share
BIVI key metrics
FY2017–FY2026| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $14.1M | — | — | — | — | — | — | — | — | — |
| Enterprise value | −$8.70T | — | — | — | — | — | — | — | — | — |
| Price / book | 0.0 | — | — | — | — | — | — | — | — | — |
| Earnings yield | −157.0% | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | −135,339.5% | — | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $1.94 | $9.25 | $40.05 | $431.00 | $145.00 | $1,695.00 | $1,400.00 | $1,312.50 | $675.00 | $3,625.00 |
| Per share | ||||||||||
| Revenue per share | $0.00 | — | — | — | — | — | — | — | — | — |
| Earnings per share | −$3.05 | — | — | — | — | — | — | — | — | — |
| Operating cash flow per share | −$2,625.59 | — | — | — | — | — | — | — | — | — |
| Free cash flow per share | −$2,625.59 | — | — | — | — | — | — | — | — | — |
| Cash per share | $1,238,953.80 | — | — | — | — | — | — | — | — | — |
| Book value per share | $1,417,385.05 | — | — | — | — | — | — | — | — | — |
| Tangible book value per share | $1,369,673.97 | — | — | — | — | — | — | — | — | — |
| Capex per share | $0.00 | — | — | — | — | — | — | — | — | — |
| Debt per share | $38,011.69 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 7.2M | — | — | — | — | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −0.0% | −101.6% | −208.3% | −528.7% | −598.2% | — | — | −218.0% | −380.4% | −86.6% |
| Return on invested capital (ROIC) | −0.0% | — | — | — | — | — | — | −147.1% | −180.3% | −82.1% |
| Return on assets (ROA) | −0.0% | −75.0% | −106.5% | −182.0% | −199.4% | — | −716.0% | −102.9% | −106.3% | −52.4% |
| Return on tangible assets | −0.0% | −83.4% | −131.3% | −147.3% | −138.0% | — | — | −362.6% | — | — |
| Financial health | ||||||||||
| Total debt | $275.43B | $349,894 | $6.1M | $14.4M | $12.3M | — | $911,043 | $0 | $825,918 | $35,000 |
| Cash & short-term investments | $8.98T | $17.5M | $23.8M | $33.9M | $18.6M | $4.5M | $37,195 | $339,923 | $45,800 | $5,140 |
| Net debt | −$8.70T | −$17.2M | −$17.7M | −$19.5M | −$6.4M | −$4.5M | $873,848 | −$339,923 | $780,118 | $29,860 |
| Debt / equity | 0.03 | 0.02 | 0.39 | 0.94 | 3.34 | — | — | 0.00 | 7.43 | 0.03 |
| Debt / assets | 0.02 | 0.02 | 0.24 | 0.41 | 0.61 | — | 0.44 | 0.00 | 0.38 | 0.01 |
| Current ratio | 3.59 | 9.10 | 2.57 | 2.35 | 4.50 | 4.62 | 0.02 | 1.52 | 0.04 | 0.01 |
| Quick ratio | 3.59 | 9.10 | 2.57 | 2.35 | 4.50 | 4.62 | 0.02 | 1.52 | 0.04 | 0.01 |
| Interest coverage | — | -54.3 | -11.1 | -10.5 | -12.6 | -246.8 | -0.6 | — | -57.9 | -7.0 |
| Working capital | $9.85T | $18.4M | $14.7M | $19.5M | $14.6M | $3.6M | −$23.1M | $230,593 | −$1.2M | −$625,833 |
| Invested capital | $1.57T | $1.8M | −$2.2M | −$4.2M | −$2.7M | $538,673 | −$20.6M | $1.8M | $891,317 | $1.2M |
| Tangible asset value | $9.92T | $18.5M | $14.8M | $14.4M | $2.5M | $3.6M | −$23.2M | $230,593 | −$2.0M | −$1.2M |
| Net current asset value | $9.66T | $18.1M | $14.3M | $14.3M | $2.3M | $3.6M | −$23.2M | $230,593 | −$2.0M | −$1.2M |
| Graham net-net per share | $689,653.50 | — | — | — | — | — | — | — | — | — |
| Capital allocation | ||||||||||
| Dividends paid | — | $369.46B | $886,423 | — | — | $53.6M | $17.1M | $48,659 | $0 | $0 |
| Share buybacks (net) | — | — | — | — | $0 | — | — | $1.1M | $0 | $0 |
| Capex / depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||||||||
| Days payables outstanding | — | 4,604.5 | 2,856.6 | 1,673.1 | 2,643.6 | 1,794.6 | 1,354.7 | 1,056.4 | 1,078.2 | 608.3 |
| Receivables turnover | 0.00 | 0.00 | — | — | — | — | — | — | — | — |
| Payables turnover | — | 0.08 | 0.13 | 0.22 | 0.14 | 0.20 | 0.27 | 0.35 | 0.34 | 0.60 |
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | $2.1M | $2.1M | — | — | — | — | — | — | — | — |
| Average payables | $3.0M | $2.9M | $1.8M | $1.2M | $1.7M | $1.1M | $851,343 | $663,844 | $677,590 | $382,303 |
| Average inventory | — | — | — | — | — | — | — | $0 | $0 | $0 |
| Intangibles / total assets | 2.4% | 2.4% | 3.0% | 2.8% | 6.0% | 23.8% | 80.2% | 73.8% | 97.9% | 99.8% |
Computed from BIVI's annual financial statements (latest annual report filed August 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BIVI valuation and financial ratios
BioVie earned a return on equity of −0.0% and a return on invested capital of −0.0% in fiscal 2026. It ended the year with $275.4 billion of debt and $8.98 trillion in cash and short-term investments, a net cash position of $8.70 trillion.
See the BIVI income statement, the BIVI chart for price history, or the BIVI stock overview for the latest quote and news.
BIVI key metrics FAQ
What is BioVie's return on equity?
BioVie's return on equity (ROE) was −0.0% in fiscal 2026: net income of -$22.1 million on average shareholders' equity of $5.14 trillion.
What is BioVie's ROIC?
BioVie's return on invested capital was −0.0% in fiscal 2026, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does BioVie have?
BioVie had total debt of $275.4 billion at the end of fiscal 2026, a debt-to-equity ratio of 0.03 and more cash than debt.
What is BioVie's free cash flow yield?
BioVie generated -$19.0 billion of free cash flow in fiscal 2026, a free cash flow yield of −135,339.5% on its market value at year-end ($14.1 million).
What is BioVie's current ratio?
BioVie's current ratio was 3.59 at the end of fiscal 2026: current assets were 3.59 times current liabilities.